News & Views
Common Coding brings Clarity to Medical Device Regulations
Aug 01 2023
The Global Medical Device Nomenclature (GMDN) has joined forces with the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) to strengthen the functionality of the MHRA's Public Access Registration Database (PARD), a significant development for medical device regulation that will improve patient safety, streamline the classification, promote transparency and enhance accessibility to vital medical device information.
By incorporating GMDN Codes into PARD, the MHRA ensures a common language and coding system that fosters seamless communication between regulatory bodies, manufacturers, healthcare professionals, and patients. It will also strengthen the MHRA's post-market surveillance capabilities enabling efficient tracking and analysis of adverse events, product recalls and safety concerns. The standardised coding system also enables rapid identification of specific device types, allowing the MHRA to take timely regulatory actions to ensure patient safety and maintain the integrity of the market.
Dr Laura Squire, MHRA Chief Healthcare Quality & Access Officer, said: “Our work with GMDN Agency to strengthen PARD will give us better data about medical devices on the market and enable us to improve our understanding of their relative safety and performance. More consistent data across MHRA systems and the wider health and social care system will be to the benefit of patients and users of medical devices.”
Another key benefit of incorporating GMDN Codes into PARD is the standardised classification of medical devices. Manufacturers registering their devices in PARD can easily select the appropriate GMDN Code that accurately represents the device's intended use and attributes. This significantly reduces errors, simplifies the registration process and saves valuable time for all stakeholders involved.
Deniz Bruce, CEO of the GMDN Agency, said, "We are delighted to collaborate with the MHRA in their pursuit of enhancing medical device regulation. The integration of GMDN within PARD will streamline processes and facilitate effective communication, ultimately promoting patient safety."
Moreover, this collaboration fosters harmonisation with international standards as GMDN Codes are widely accepted and used by more than 70 regulatory authorities worldwide.
More information online
Digital Edition
Lab Asia 31.6 Dec 2024
December 2024
Chromatography Articles - Sustainable chromatography: Embracing software for greener methods Mass Spectrometry & Spectroscopy Articles - Solving industry challenges for phosphorus containi...
View all digital editions
Events
Nov 27 2024 Istanbul, Turkey
Jan 22 2025 Tokyo, Japan
Jan 22 2025 Birmingham, UK
Jan 25 2025 San Diego, CA, USA
Jan 27 2025 Dubai, UAE